Medeon Biodesign Inc develops medical device products. It is developing devices for invasive surgeries and for treating diseases including cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, & nephrology. The company provides products in fields of cardiovascular and laparoscopic.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.13 | $2.11 | $1.06 - $2.69 | $141M | 66.1M | 58.2K | -$0.10 |
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|---|
EV | 89,346 | 89,346 | 92,446 | 113,440 |
Revenue | 22,215 | 22,215 | 14,684 | 22,326 |
EBITDA | (1,227) | (1,227) | (6,140) | 8,821 |
Net Income | (6,548) | (6,548) | (8,478) | 8,506 |
Total Assets | 118,823 | 118,823 | 84,037 | 63,675 |
Total Debt | 17,666 | 17,666 | 3,951 | 1 |
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Medeon Biodesign‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Yue-Teh Jang Ph.D | Founder, Chairman, President & Chief Executive Officer | ||
Shuling Cheng Ph.D | Chief Strategy Officer |
Name | Representing | Role | Since |
---|---|---|---|
Yue-Teh Jang Ph.D | Medeon Biodesign | Founder, Chairman, President & Chief Executive Officer | 000 0000 |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 0000000000 | 31-May-2019 | 000000000 | Therapeutic Devices | ||
Panther Orthopedics | 28-Mar-2018 | Corporate | Therapeutic Devices | 000-000 0000 00.0 |